Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 21,493 | 2,482 | 1,590 | 1,937 | 1,973 |
| Operating Income | -21,493 | -2,482 | -1,590 | -1,937 | -1,973 |
| Interest Expense | 750 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 473 | 501 | 513 | 493 |
| Pre-tax Income | -22,243 | -2,009 | -1,089 | -1,424 | -1,480 |
| Net Income Continuous | -22,243 | -2,009 | -1,089 | -1,424 | -1,480 |
| Net Income | $-22,243 | $-2,009 | $-1,089 | $-1,424 | $-1,480 |
| EPS Basic Total Ops | -6.96 | -1.68 | -0.96 | -1.20 | -1.20 |
| EPS Basic Continuous Ops | -6.96 | -1.66 | -0.91 | -1.19 | -1.23 |
| EPS Diluted Total Ops | -6.96 | -1.68 | -0.96 | -1.20 | -1.20 |
| EPS Diluted Continuous Ops | -6.96 | -1.66 | -0.91 | -1.19 | -1.23 |
| EPS Diluted Before Non-Recurring Items | -2.16 | -1.68 | -0.96 | N/A | N/A |
| EBITDA(a) | $-21,481 | $-2,463 | $-1,567 | $-1,907 | $-1,944 |